Automatic analysis of EMG (T/A analysis) and invasive muscle fiber conduction velocity in situ (MFCV) were performed in 15 patients after traumatic lesions of the knee and immobilization with quadriceps atrophy. T/A analysis showed transient reduced number of turns, consistent with inhibition of quadriceps motoneurons, that recovered within the first 2 weeks after the plaster cast had been removed. MFCV was significantly slowed and showed a gradual improvement, reaching normal values after 6 weeks. These results suggest that decrement in activated motor units may be the cause of the disproportionate weakness of the quadriceps muscle on the first days after immobilization by the plaster cast. The recovery of MFCV was related with functional improvement of strength after the first weeks.

Keywords:
Disuse, Atrophy of muscle fibers, Conduction velocity in situ, Automatic analysis of the EMG
1.
Patel AN, Ruzzak Z, Dustur D: Disuse atrophy of skeletal muscle. Arch Neurol (Chic) 1969;20:413–421.
2.
Stener B, Petersen I: Electromyographic investigation of reflex effects upon stretching partially ruptured medial collateral ligament on knee joint. Acta Chir Scand 1962;124:396–411.
3.
Spencer JD, Hayes XC, Alexander I: Knee joint effusion and quadriceps reflex inhibition in man. Arch Phys Med Rehabil 1984;65:171–177.
4.
Swearingen RI, Dehne E: Study of pathological muscle function following injury to joint. J Bone Joint Surg 1964;46:1364.
5.
Fahrer H, Pentesch HH, Gerber NJ, Beyeler Ch, Hess Ch, Grünig E: Knee effusion and reflex inhibition of the quadriceps. J Bone Joint Surg [Br] 1988;70:635–638.
6.
Fitch P, Willison RG: Automatic measurement of the human electromyogram. J Physiol (Lond) 1965;178:28–29.
7.
Cruz-Martínez A, Ferrer MT, Pérez-Conde MC: Automatic analysis of the electromyogram. Studies in patients with primary muscle diseases and neurogenic involvement. Comparison of diagnostic yield versus individual motor unit potential parameters. Electromyogr Clin Neurophysiol 1984;24:417–438.
8.
Fuglsang-Frederiksen A, Manson A: Analysis of electrical activity of normal muscle in man at different degrees of voluntary effort. J Neurol Neurosurg Psychiatry 1975;38:683–694.
9.
Troni W, Cantello R, Rainero I: Conduction velocity along human muscle fibers in situ. Neurology 1983;33:1453–1459.
10.
Troni W, Doriguzzi C, Mongini T: Interictal conduction slowing in muscle fibers in hypokalemic periodic paralysis. Neurology 1983;33:1522–1525.
11.
Cruz-Martínez A, López-Terradas JM: Conduction velocity in human muscle fibers in situ. Study in upper and lower limbs in healthy adults. Electromyogr Clin Neurophysiol 1989;29:363–368.
12.
Cruz-Martínez A, López-Terradas JM: Conduction velocity along muscle fibers in situ in Duchenne muscular distrophy. Arch Phys Med Rehabil 1990;71:558–561.
13.
Cruz-Martínez A, Arpa J: Muscle fiber conduction velocity in situ in hypokalemic periodic paralysis. Acta Neurol Scand 1997;96:229–235.
14.
Gibson JA, Smith K, Rennie MJ: Prevention of disuse muscle atrophy by means of electrical stimulation: Maintenance of protein synthesis. Lancet 1988;ii:767–770.
15.
Andersen P, Henrikssen J: Training-induced changes in the subgroups of human Type 2 skeletal muscle fibers. Acta Physiol Scand 1977;99:123–125.
16.
Fischbach GD, Robbins N: Changes in contractile properties in disused soleus muscle. J Physiol 1969;201:305–320.
17.
Davis CJF, Montgomery A: The effect of prolonged inactivity upon contraction characteristics of fast and slow mammalian twitch muscle. J Physiol 1977;270:581–594.
18.
Fuglsang-Frederiksen A, Scheel U: Transient decrease in number of motor units after immobilization in man. J Neurol Neurosurg Psychiatry 1978;41:924–929.
19.
Serra G, Tugnoli V, Elcopra R, Quatrale R, Faccini R, Basaglia N: Neurophysiological evaluation of the muscular hypotrophy after immobilization. Electromyogr Clin Neurophysiol 1989;29:29–31.
20.
Stålberg E: Propagation velocity in human muscle fibers in situ. Acta Physiol Scand 1966;287(suppl 70):1–112.
21.
Fuglsang-Frederiksen A, Scheel U, Buchthal F: Diagnostic yield of analysis of the pattern of electrical activity and individual motor unit potentials in myopathy. J Neurol Neurosurg Psychiatry 1976;39:742–750.
22.
Fuglsang-Frederiksen A, Scheel U, Buchthal F: Diagnostic yield of analysis of the pattern of electrical activity of muscle and of individual motor unit potentials in neurogenic involvement. J Neurol Neurosurg Psychiatry 1977;40:544–554.
23.
De Andrade JR, Grant C, Dixon A: Joint distension and reflex muscle inhibition in the knee. J Bone Joint Surg [Am] 1965;47:313–322.
24.
Hakansson CH: The propagation velocity in isolated frog muscle fibers. Acta Physiol Scand 1954;31(suppl 114):22–23.
25.
Hakansson CH: Conduction velocity and amplitude of the action potentials as related to circumference in the isolated fiber in frog muscle. Acta Physiol Scand 1956;37:14–34.
26.
Buchthal F, Guld C, Rosenfalck P: Propagation velocity in electrically activated muscle fibers in man. Acta Physiol Scand 1955;34:75–89.
27.
Brooke MH, Engel WR: The histographic analysis of human muscle biopsies with regard to fiber types. I. Adult male and female. Neurology 1969;19:221–233.
28.
Van der Hoeven JH, Zwarts I, Van Weerden TW: Muscle fiber conduction velocity in amyotrophic lateral sclerosis and traumatic lesions of the plexus brachialis. Electroencephalogr Clin Neurophysiol 1993;89:304–310.
29.
Stålberg E: Electrogenesis in human dystrophic muscle. Excerpta Med Int Congr Ser 1976;404:570–589.
30.
Honk J, Henneman E: Response of Golgi tendon organs to activated contractions of the soleous muscle in cat. J Neurophysiol 1967;30:466–481.
© 2000 S. Karger AG, Basel
2000
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.